Login / Signup
A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission.
Anas Gremida
Parakkal Deepak
Published in:
Crohn's & colitis 360 (2021)
Keyphrases
</>
ulcerative colitis
disease activity
systemic lupus erythematosus
adverse drug
drug induced